Faes Farma SA
MAD:FAE
Faes Farma SA
Cash Interest Paid
Faes Farma SA
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Faes Farma SA
MAD:FAE
|
Cash Interest Paid
€433k
|
CAGR 3-Years
26%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
|
Almirall SA
MAD:ALM
|
Cash Interest Paid
€10.5m
|
CAGR 3-Years
20%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-2%
|
|
|
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
|
Cash Interest Paid
€1.8m
|
CAGR 3-Years
82%
|
CAGR 5-Years
57%
|
CAGR 10-Years
-3%
|
|
|
Laboratorio Reig Jofre SA
MAD:RJF
|
Cash Interest Paid
€2m
|
CAGR 3-Years
30%
|
CAGR 5-Years
13%
|
CAGR 10-Years
23%
|
|
|
L
|
Labiana Health SA
MAD:LAB
|
Cash Interest Paid
€3.3m
|
CAGR 3-Years
40%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Faes Farma SA
Glance View
Faes Farma SA, a notable player in the pharmaceutical arena, has orchestrated its operations with the precision of a seasoned conductor. Rooted in Spain with an impressive international reach, the company blends research prowess with adept production capabilities. Central to its modus operandi is the development, manufacture, and commercialization of a wide range of pharmaceutical products and nutritional supplements. With science as its guiding star, Faes Farma dedicates substantial resources to research and development, ensuring a pipeline filled with innovative treatments that cater to diverse medical needs. The company has carved its niche by focusing on therapeutic areas such as allergy, dermatology, and the central nervous system, allowing it to create specialized solutions that resonate well with healthcare providers and patients alike. The company’s revenue engine is driven primarily by its robust product sales, enhanced by strategic partnerships and licensing agreements that bolster its market presence both in Spain and across global markets. Through rigorous production processes, Faes Farma ensures the delivery of high-quality medications, matching industry standards and fostering consumer trust. Additionally, its geographical diversification, with subsidiaries and distribution channels spreading across Europe, Latin America, and Africa, underpins its economic durability. By marrying innovation with strategic commercial tactics, Faes Farma has deftly navigated the complexities of the pharmaceutical landscape, ensuring not only profitability but also the sustained delivery of health-enhancing products to the global community.
See Also
What is Faes Farma SA's Cash Interest Paid?
Cash Interest Paid
433k
EUR
Based on the financial report for Dec 31, 2024, Faes Farma SA's Cash Interest Paid amounts to 433k EUR.
What is Faes Farma SA's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
53%
Over the last year, the Cash Interest Paid growth was 13%. The average annual Cash Interest Paid growth rates for Faes Farma SA have been 26% over the past three years , 53% over the past five years .
You don't have any saved screeners yet